# Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks

> **NCT00297180** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 136 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** GW869682

## Key facts

- **NCT ID:** NCT00297180
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2015-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297180, "Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00297180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*